Heparanase enhances myeloma progression via CXCL10 downregulation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Heparanase enhances myeloma progression via CXCL10 downregulation

Published:2014-04-04 Issue:11 Volume:28 Page:2178-2187
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Barash U,Zohar Y,Wildbaum G,Beider K,Nagler A,Karin N,Ilan N,Vlodavsky I

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2014121.pdf

Reference55 articles.

1. Arvatz G, Shafat I, Levy-Adam F, Ilan N, Vlodavsky I . The heparanase system and tumor metastasis: is heparanase the seed and soil? Cancer Metastasis Rev 2011; 30: 253–268.

2. Barash U, Cohen-Kaplan V, Dowek I, Sanderson RD, Ilan N, Vlodavsky I . Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis. FEBS J 2010; 277: 3890–3903.

3. Ilan N, Elkin M, Vlodavsky I . Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Intl J Biochem Cell Biol 2006; 38: 2018–2039.

4. Vlodavsky I, Ilan N, Naggi A, Casu B . Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr Pharm Des 2007; 13: 2057–2073.

5. Vreys V, David G . Mammalian heparanase: what is the message? J Cell Mol Med 2007; 11: 427–452.

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets;International Journal of Molecular Sciences;2024-06-13

2. CXCL10 and IL15 co-expressing chimeric antigen receptor T cells enhance anti-tumor effects in gastric cancer by increasing cytotoxic effector cell accumulation and survival;OncoImmunology;2024-05-24

3. T-cell subsets and cytokines are indicative of neoadjuvant chemoimmunotherapy responses in NSCLC;Cancer Immunology, Immunotherapy;2024-04-15

4. Canagliflozin reduces thyroid cancer cells migration in vitro by inhibiting CXCL8 and CCL2: An additional anti-tumor effect of the drug;Biomedicine & Pharmacotherapy;2024-01

5. Hydrogel-mediated tumor T cell infiltration and immune evasion to reinforce cancer immunotherapy;Nanoscale Horizons;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3